The prostacyclin analogue taprostene and recombinant human superoxide dismutase increase the permanent survival rate of endotoxemic rats
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 46 (20) , 1421-1426
- https://doi.org/10.1016/0024-3205(90)90457-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsisIntensive Care Medicine, 1988
- PROPHYLACTIC AND CURATIVE EFFECTS OF RECOMBINANT HUMAN SUPEROXIDE-DISMUTASE IN LETHAL RAT ENDOTOXEMIA1988
- Salutary effects of the prostacyclin analogue CG 4203 in lethal endotoxemia in ratsProstaglandins, Leukotrienes & Essential Fatty Acids, 1988
- Endotoxins, Arachidonic Acid, and Superoxide FormationClinical Infectious Diseases, 1987
- Profiles of Endogenous Prostaglandin F2α, Thromboxane A2 and Prostacyclin with regard to Cardiovascular and Organ Functions in Early Septic Shock in ManEuropean Surgical Research, 1987
- INHIBITION OF LIPID-PEROXIDATION IMPROVES SURVIVAL RATE OF ENDOTOXEMIC RATS1987
- Prostacyclin Reversal of Lethal Endotoxemia in DogsJournal of Clinical Investigation, 1981
- THE EFFECTS OF PROSTACYCLIN (PGI2) ON ENDOTOXIN-SHOCK AND ENDOTOXIN-INDUCED PLATELET-AGGREGATION IN DOGS1980